Phosphoinositol turnover, diacylglycerol generation, protein kinase C (PK-C) activity, and intracellular cyclic nucleotides were studied in an established human leukemia cell line, HL-60, in response to one of the hematopoietic cytokines, granulocyte-macrophage colony-stimulating factor (GM-CSF). Continuous exposure of HL-60 cells to GM-CSF induced the cell differentiation that was evaluated by the nitroblue tetrazolium (NBT) reducing activity. GM-CSF also exhibited a proliferative effect on HL-60 cells. GM-CSF at 1 nmol/L, an optimal concentration for cell growth and cell differentiation, induced significant changes in the intracellular inositoltriphos-HE HEMATOPOIETIC stem cells are thought to be T regulated by a group of cytokines, such as multi-colonystimulating factor interleukin-3 (IL-3), macrophage colonystimulating factor (M-CSF), granulocyte-CSF (G-CSF), and granulocyte-macrophage-CSF (GM-CSF) in their survival, proliferation, and differentiation. GM-CSF potentiates the proliferation and differentiation of megakaryocyte colony-forming units (CFU-Meg) and burst-forming unitserythroid (BFU-E) as well as CFU-granuiocyte-macrophage in human bone marrow cultures.*,2 In addition to the growth effect toward hematopoietic precursors, GM-CSF induces the priming effect of cells for the enhancement of their functional responsiveness in human mature neutrop h i l~.~ Furthermore, GM-CSF also enhances the colony growth of human promyelocytic leukemia cell line, HL-60, as well as normal progenitors, characterized by increasing the cell number in suspension culture and an increase in 3H-thymidine ~p t a k e .~,~ In addition to the proliferative effect, GM-CSF is also known to induce maturations in HL-60 cells6 and in an established monoblastic leukemia cell line, U937.7 The human leukemia cell line HL-60 is often used as a model of the myeloid progenitor cell. Although GM-CSF promotes the normal hematopoiesis and the HL-60 cell growth and maturation, it is not fully understood how GM-CSF transmits its signals after its specific binding to the GM-CSF receptor, eventually leading to multiple biologic responses.
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Coffey et alp reported that GM-CSF stimulated guanylate cyclase activity and reduced adenylate cyclase activity in human neutrophils. In experiments to examine the pathway of GM-CSF action, Sullivan et a19 observed no changes in inositol lipid breakdown, intracellular calcium ion, or translocation of protein kinase C (PK-C). Thus, cyclic nucleotides appear to play the major role in the priming effect of GM-CSF toward human neutrophils. However, multiple actions of GM-CSF provide the implication that the signal transduction of GM-CSF is not always simple.
In this report, we describe the biologic actions of GM-CSF toward HL-60 cells. We also investigate whether GM-CSF affects phosphoinositol turnover, PK-C activity, and the metabolism of cellular cyclic nucleotides to assess the mechanism of GM-CSF signal transduction. phate (IPS). Diacylglycerol generation was also stimulated by GM-CSF treatment. GM-CSF increased the membrane PK-C activity by IO-fold of the control, whereas no measurable change in cyclic nucleotides was observed. These data indicated that phosphoinositol turnover and the activation of PK-C were included in the GM-CSF signal transducing pathway in HL-60 cell. Phosphoinositol response leading to PK-C activation may act as a trigger signal of cell differentiation by 0 1992 by The American Society of Hematology.
GM-CSF.

MATERIALS AND METHODS
Recombinant human GM-CSF was a gift from Hoechst Japan Co (Tokyo, Japan). The HL-60 cell was obtained from Japanese Cancer Research Resources Bank (JCRB Tokyo, Japan). 12-0-tetradecanoyl-13-acetate (TPA), 1,2-dioleoyl-glycero1 (DOG), phosphatidylserine, and nitroblue tetrazolium (NBT) were purchased from Sigma Chemical Co (St Louis, MO). 3H-Thymidine 80.7Ci/ mmol was purchased from DuPont New England Nuclear (Boston, MA). 3H-myoinositol (80 to 120 Cilmmol) and [Y~~P]-ATP (33Ci/ mmol) were obtained from Amersham Japan Co (Tokyo, Japan). All other chemicals were purchased from standard sources.
HL-60 cells were cultured in RPMI 1640 medium supplemented with 10% heat-inactivated fetal calf serum (FCS), penicillin (50 U/mL), streptomycin (50 pg/mL), and 0.2% (wt/vol) sodium bicarbonate in 5% C02/95% humidified air. The cells were routinely passaged with medium changes once or twice a week. Cells with passaged number below 20 weeks were used for the experiments.
HL-60 cells at 2.0 x 105/mL were cultured in 5% FCS-RPMI 1640 medium using a 24-well plastic plate with various concentrations of GM-CSF over a 5-day period without medium change. Cell viability was determined by trypan blue dye exclusion test, and cell numbers were counted in duplicate.
To assess the effect of GM-CSF on thymidine uptake into HL-60 cells, 2.0 x lo4 cells were incubated in 5% FCS-RPMI 1640 medium with or without GM-CSF using a 96-well microliter plate. After 24 hours of culture, cells were pulsed with 2 FCi of 3H-TdR for 2 hours, followed by the addition of 10% formalin to terminate the incubation. The cells
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After 5 days of culture with various concentrations of GM-CSF, HL-60 cells (3.0 x IOh) in 5% FCS-RPMI 1640 medium containing 0.5 mg/mL NBT and 10 pg/mL TPA were incubated for 30 minutes at 37°C. After a brief centrifugation, the cell pellets were resuspended in 1,OOO p L of dimethyl sulfoxide (DMSO) and the amounts of formazan were measured by checking the absorbance at 595 nm in duplicate.
HL-60 cells were incubated for 48 hours in 10% FCS-RPMI 1640 medium containing5 pCi/mLof 'H-myoinositol to determine the phosphoinositol turnover. Before the assay for effector-stimulated generation of inositolphosphates. the cells were washed in RPMl 1640 medium containing 10 mmol/L LiCl (assay medium). and were allowed to incubate in the same medium for 15 minutes at 3 7 T . Stock solutions of effectors (100-fold concentrated) in the assay medium were added to give final concentrations of either 1 nmol/L GM-CSF or 10 mmol/L NaF plus 5 pmol/L AI~(SOJ)J for a positive control. At fixed time intervals, the medium was removed and the incubation (3.0 x 1oh cells for each cultures) was terminated by an addition of 10% (vol/vol) trichloro-acetic acid (TCA), and samples were kept on ice for 10 minutes to extract the acid-soluble inositol phosphates. TCA was removed by ether extraction and the samples were loaded onto Dowex formate resin (AGI-X8; Bio-Rad, Richmond, CA) in plastic columns after adjustment of pH with 0.2 mol/L Tris. Inositol phosphates were separated by a similar method described by Wahl et a1.I'' The columns were thoroughly washed with 10 mmol/L myoinositol to estimate intracellular free inositol. The columns were washed again with 60 mmol/L ammonium formatel5 mmol/L disodium tetraborate to remove 'H-myoinositol and 'Hglycerophosphoinositol. Then the samples were eluted with a step gradient of 2 0 mmol/L to 1.0 mol/L ammonium formate in 100 mmol/L formic acid: 200 mmol/L ammonium formate/100 mmol/L formic acid for the estimation of IPI, 400 mmol/L ammonium formate/100 mmol/L formic acid for IP2, and 1.0 mol/L ammonium formate/100 mmol/L formic acid for IP, isomers and IP4, respectively. The column fractions were collected and counted for radioactivity after an addition of scintillation cocktail. All experiments were performed in triplicates. Statistical analysis were made by the Student's t-test.
HL-60 cells (1.0 x IO'ceIls for each assay tube) were incubated with 1 nmol/L GM-CSF or control medium for indicated periods. Cell samples were extracted by a modified method of Bligh and Dyer." The DAG assay was performed according to the manufacturer's directions (Amersham DAG assay reagents system, Amersham). The basis of the assay system is a radioenzymatic assay using the enzyme diacylglycerol kinase that quantitatively converts DAG to ['?P]-phosphatidic acid (PA) in the presence of [y"?P]-ATP. Reactions were stopped by the addition of 20 p L of 1% perchloric acid (PCA) and 450 p L of chloroform/methanol (1:2), and the reaction products, which contained labeled PA, were extracted and then separated by thin-layer chromatography (HPTLC,LHP-KDF Whatman, Maidstone, UK). The zone corresponding to ['?P]-PA was visualized by submitting the TLC plates to autoradiography overnight. The bands corresponding to [-'*P]-PA were scraped into scintillation vials and counted for radioactivities.
HL-60 cells (3.0 x IO7/mL) were treated with 1 nmol/L GM-CSF or 100 nmol/L TPA in serum-free culture medium at 3PC for the indicated intervals. Stock solutions of GM-CSF and TPA were prepared in 10% (vollvol) DMSO-RPMI 1640 medium, and added into culture medium to give the final concentration of 0.1% DMSO. Untreated control cells received an equivalent amount of DMSO. Membrane and soluble fractions A stock solution containing both phosphatidylserine and DOG in chloroform was evaporated under nitrogen and dispersed in water by sonicating three times for 1 minute. Nonspecific enzyme activity was determined in the absence of phosphatidylserine and DOG. Reaction tubes were incubated for 20 minutes at 30°C and the assay was completed as described by Uchida and Fiburn.IJ Measurement of inrrizcellitlar qclic nctcleorides. HL-60 cells were washed three times with complete RPMl 1640 medium and resuspended in serum-free medium to make 1 mL of aliquots (4.0 x loh/mL for CAMP and 4.0 x IOX/mL for cGMP) with or without 1 nmol/L GM-CSF. After the indicated period of incubation, the cells were sonicated in 0.1N HCI, and cellular cyclic nucleotides were quantitated by radio-immunoassay (RIA) (CAMP and cGMP assay kit; Yamasa Shoyu Co. Tokyo, Japan). days and examined for their ability to reduce NBT. NBT reduction is often used as a positive marker for myeloid cell maturation.' GM-CSF significantly induced NBT reducing activity in HL-60 cells in a dose-dependent manner (Fig 3) . We also evaluated the percentage of cells containing formazan deposits and confirmed that an increase in the ratio of formazan deposit-positivc cells was directly proportional to an increase in the absorbance at 595 nm (data not Biologic effects of GM-CSF on HL-60 cell. containing 3H-myoinositol-labcIcd components, which were prcviously idcntificd as inositol phosphatcs, wcrc monitored." Approximatcly 2. Fig 4. GM-CSF trcatmcnt for I to 15 minutcs incrcascd thc lcvcl of DAG by 120% to 130% of thc control cclls. The levcl of DAG was then dccrcascd. but not returned to thc basal lcvcl within 60 minutcs. Thus, GM-CSF causcd an accumulation of both IP3 and DAG by stimulating hydrolysis of phosphatidyl inositol bis-phosphates (PIP:).
RESULTS
As shown in
GMCSF(M)
In gcncral. phosphoinositol brcakdown produccs two signal mediators, IP3 and DAG, leading to thc activation of PK-C. In thc ncxt set of cxpcrimcnts, wc cxamincd GM-CSF-induced PK-C activation. Figurc 5 shows the cffccts of GM-CSF and a phorbol cstcr (TPA) on the PK-C activity in HL-60 cclls. In untrcatcd cells. the activity of PK-C was cxtremcly low in thc mcmbranc fraction (less than 5% of total). GM-CSF trcatmcnt for 5 minutcs incrcascd thc PK-C activity in thc mcmbranc fraction 10-fold. and dccrcascd thc enzyme activity in thc cytosol fraction. Thc mcmbranc PK-C activity was then rcturncd to basal lcvcl within 60 minutcs in GM-CSF trcatmcnt. TPA also incrcascd thc PK-C activity in thc mcmbranc fraction of HL-60 cclls. Howcvcr, the cffcct of TPA pcrsistcd for a longcr period as comparcd with GM-CSF (grcatcr than 60 minutes).
To asscss thc rolc of cyclic' nuclcotidcs as the sccond mcsscnDAGgeneration after GM-CSF treatment.
Activation of PK-C by GM-CSF.
Effect of GM-CSF on the level of cyclic nucleotide. gers mediating the effect of GM-CSF, the intracellular cyclic AMP and cyclic GMP accumulations in HL-60 cells were investigated. As shown in Fig 6 A and B , no significant elevation of cyclic nucleotides was observed in the cells treated with 1 nmol/L GM-CSF for 90 minutes. In the presence of theophylline, a phosphodiesterase inhibitor, GM-CSF did not induce the significant accumulation of cyclic nucleotides (data not shown).
DISCUSSION
The present results first showed the modifying effects of GM-CSF on the phosphoinositol turnover, DAG formation, and the activity of PK-C using the HL-60 cell line established as a model of myeloid progenitor. The multiple actions of CSF on responsive hematopoietic cells must be mediated initially through the recognition of a CSF by its specific binding sites, and then by the transduction of the recognition into intracellular molecular interactions leading to biologic response. The previous reports showed the presence of GM-CSF-specific binding sites on HL-60 cells and the stimulatory effects of GM-CSF on the process of HL-60 cell proliferation and differentiation?"'" In the present study, to confirm the biologic actions of GM-CSF on the HL-60 cell line, we first examined the effects of GM-CSF on the cell growth and the cell maturation characterized by NBT reducing activity of the cells. GM-CSF produced both proliferative and differentiative effects in a dose-dependent manner. Begley et a16 reported that GM-CSF induced HL-60 cell differentiation characterized by expression of granulocyte and macrophage surface antigens without morphologic changes. Adding to the differentiative effect, they observed a growth-promoting effect of GM-CSF toward HL-60 cells, as also shown in the present study. The concentration of GM-CSF at 1 nmol/L, which induced an optimal biologic effect in this study, corresponds with the dissociation constant of GM-CSF receptor as reported previously.".'h It is well known that phorbol esters, such as TPA, a potent activator of PK-C, induce a monocytic differentiation of HL-60 ~e l l s . 1~ Indeed, we observed an inhibitory effect of TPA on HL-60 cell growth and a stimulatory effect on cell differentiation (data not shown). In addition, the recent report showed that sustained activation of PK-C is essential to HL-60 cell differentiation.IR This evidence suggests that an activation of PK-C after GM-CSF stimulation observed in this study is a signal of cell differentiation, but not proliferation.
There are three major signal transducing pathways by which growth factors mediate their effects on cell proliferation and differentiation: the adenylate cyclase system, which accumulates intracellular cyclic AMP level; hydrolysis of phosphoinositides, leading to the activation of PK-C; and autophosphorylation of the receptor itself, followed by the activation of tyrosine kinase. The recent studies showed that the priming effect of GM-CSF on human mature neutrophils was associated with a significant change in cellular cyclic nucleotides, but not with phosphoinositol turnover and PK-C In contrast, we observed no measurable changes in cyclic nucleotides in HL-60 cells treated with GM-CSF. Our results also showed GM-CSF stimulation of the phosphoinositol turnover and the translocation of PK-C from cytosol to membrane fraction in HL-60 cells. These observations may suggest the different mechanisms of GM-CSF signal transduction in various tissues, by which multiple functions, such as the priming effect on human neutrophils and the growth or maturation on HL-60 cells, can be mediated.
As for the receptor-mediated signal transduction system, Nicolalg suggested the existence of a common converting subunit associated with low-affinity binding subunits, which regulates the formation of high-affinity human GM-CSF and IL-3 receptors, and the transmission of each biologic signal. Thereafter, it was shown that the high-affinity GM-CSF receptor was composed of two separate components, a and p subunits.20.21 The a chain might be identical to the low-affinity receptor, but whether the p chain was identical to a common converting subunit or not was still unknown.
On the other hand, platelet-derived growth factor (PDGF) and its receptor-associated signal complexes are For personal use only. on September 24, 2017. by guest www.bloodjournal.org From well known as a model of signal transduction pathway with respect to a phosphoinositol tumover.22.23 PDGF receptors are phosphorylated on tyrosine residue in response to its ligand binding. The recent study by Kaplan et alZ4 showed that PDGF stimulates the tyrosine phosphorylation of GTPase activating protein (GAP), phospholipase-C y (PLC-y) and phosphatidylinositol-3 kinase (PI3-K). PDGF binding to its receptors also stimulates the formation of the receptor-associated signal complexes leading to phosphoinositol turnover. After GM-CSF stimulation, many phosphorylation events occurred on tyrosine residues in some cell l i n e~.~~-~O However, neither the a nor p subunits possess a tyrosine kinase d0main.2~3~~ Therefore, it is possible that an unidentified separate molecule that possesses a tyrosine kinase activity such as src-type tyrosine kinase may also play a regulatory role in the GM-CSF signalling system. A receptor tyrosine kinase, such as PDGF, produces a signal complexes formation that is composed from PLC-y, PD-K, GAP, and Raf-1.2"" Taking these findings together, it is also possible that a signal complexes formation after GM-CSF stimulation may induce a rapid phosphorylation of Raf-1,32 and a phosphoinositol response leading to PK-C activation that is demonstrated in our present study. Satoh et aP3 predicted the existence of nonreceptor type tyrosine kinase(s) in the postreceptor signal transduction pathway. They also suggested that tyrosine kinases involved in GM-CSF signal transduction pathway are essential for the cell growth stimulated by this growth factor. Thus, it is likely that GM-CSF involves two different biologic responses, the proliferation and differentiation of its responsive cells, through tyrosine kinase activation. To our knowledge, this is the earliest report that shows the stimulatory effect of GM-CSF on phosphoinositol turnover and PK-C activity in HL-60 cell, probably leading to the cell differentiation. More extensive studies, including an interaction between tyrosine kinase and phosphoinositol response, and calcium mobilization, are required to elucidate the precise mechanism of GM-CSF action on its responsive cells. For personal use only. on September 24, 2017. by guest www.bloodjournal.org From
